Interactive vs. Standard Video Education for Improving Outcomes in Hemodialysis Patients
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Educational Method Using Interactive Video, Educational Method Using Conventional Video.
- Who it may be relevant to
- Registry conditions: Hemodialysis, Nurse, Educational Videos, Patient Activation. Basic parameters: 18 years — 65 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Center list to be confirmed — check the primary protocol.
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Examining the Effects of Interactive Versus Conventional Video-Based Education on Activation, Treatment Adherence, and Weight Changes in Dialysis Patients: A Randomized Clinical Trial Protocol
Overview
The goal of this clinical trial is to find out if educational videos-especially interactive ones-can help people on dialysis better manage their treatment. Researchers want to answer the following main questions: Can interactive or conventional video-based education help patients better understand and follow their treatment plan? Does this type of education improve patients' ability to control their weight changes between dialysis sessions? Does this type of education improve patients' activation? Is interactive video education more effective than regular (non-interactive) video education? What Will Happen in the Study: Adults on hemodialysis will take part in the study. They will be randomly assigned to one of three groups: Group A: Will receive 10 interactive educational video sessions (30 minutes each). Group B: Will receive the same videos but in a non-interactive format. Group C (Control Group): Will receive routine education normally given at the dialysis center. Videos will be watched on a web platform. Interactive videos include pop-up questions and scenario-based feedback. All participants will be followed up immediately, 1 month, and 3 months after the program ends. What Participants Will Do: Watch educational videos over several days (totaling 5 hours). Answer questions and engage in follow-up group discussions. Complete surveys about their knowledge, treatment adherence, and health behaviors. Get weighed before and after dialysis sessions to monitor fluid retention. This study aims to improve how dialysis patients manage their condition and to help healthcare providers design better educational tools.
Interventions
- Other Educational Method Using Interactive Video
Phase 1 - Interactive Video-Based Training (10 sessions of 30 minutes each): Patients will access the platform via the website https://spotplayer.ir/ and watch a comprehensive interactive video related to end-stage renal disease (ESRD) and its replacement therapies. This video consists of ten 30-minute sessions, uploaded at the rate of one session per day. During the viewing, pop-up questions will appear, which patients are required to answer. Different response options will lead to the present - Other Educational Method Using Conventional Video
This educational intervention will be carried out in two phases with a total duration of six hours. A total of 55 patients will participate in this study, organized into groups of five and guided by an experienced instructor familiar with the interactive video-based educational system. Phase 1 - Conventional Video-Based Training (10 sessions of 30 minutes each): Patients will access the platform through the website https://spotplayer.ir/ and watch in-depth educational videos related to end-sta
Primary outcome measures
- Patients Activation Measure [Time frame: Baseline (prior to the intervention) Immediately after the completion of the intervention One month post-intervention Three months post-intervention]
Secondary outcome measures (2)
- Treatment Adherence [Time frame: Baseline (prior to the intervention) Immediately after the completion of the intervention One month post-intervention Three months post-intervention]
- Patient Weight Changes [Time frame: Baseline (prior to the intervention) Immediately after the completion of the intervention One month post-intervention Three months post-intervention]
Eligibility criteria
Inclusion criteria
- Willingness to participate in the study;
- Literate (ability to read and write);
- Alertness and orientation to time, place, and person sufficient to respond to questions;
- No history of hearing or visual impairments;
- No cognitive disorders;
- Possession of a personal mobile phone or any other device capable of running interactive videos, and the ability to use it;
- No use of psychoactive medications;
- Confirmed diagnosis of chronic kidney disease by a nephrology specialist and having a medical record in the dialysis unit;
- Age between 18 and 65 years.
Exclusion criteria
- Withdrawal from the study at any stage;
- Failure to receive and watch the provided videos;
- Patient death;
- Transfer to a healthcare center outside the coverage of Shahid Beheshti University of Medical Sciences.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Open label
- Primary purpose
- Other
Study locations
Center list to be confirmed — check the primary protocol.
Publications
- Sarmadi S, Sanaie N, Zare-Kaseb A. Comparing the effects of interactive and conventional video education on activation, treatment adherence, and weight changes in dialysis patients: A randomized clinical trial protocol. PLoS One. 2025 Oct 15;20(10):e0334498. doi: 10.1371/journal.pone.0334498. eCollection 2025. PMID 41091721
Identifiers
NCT: NCT07099326 · IR.SBMU.PHARMACY.REC.1404.067